Clinical Trial

A Multicenter, Open, Comparative Study on Vaginal Dysbiosis in Premenopausal Women (DISPALOMA)

Study acronym: DISPALOMA
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 3, 2025 (before its estimated May 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
The hypothesis is raised of improving the status of vagnal microbiota with a non-hormonal topical product in early situations of dysbiosis in which the vaginal pH is elevated and the patient may or may not be symptomatic, in order to try to prevent the appearance of future established vaginal infections.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-30.
Status change: Not Yet Recruiting → Recruiting 2025-01-30
Trial Details
NCT Number NCT06668012
Lead Sponsor Procare Health Iberia S.L.
Conditions Vaginal Dysbiosis
Enrollment 30 participants
Start Date 2024-12-12
Primary Completion 2025-05-20 (estimated)
Study Completion 2025-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-03